Evidence map

ArticleMolecular medicine (Cambridge, Mass.)2025

Mirabegron treatment reduces myofibroblasts and CXCR2 expression in adipose tissue in obesity.

Brian S Finlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41087927